We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Photo: belyaaa via 123rf New research employing mRNA technology — which gained prominence during the COVID-19 pandemic — may offer the key to developing a cure for HIV. One of the chief ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Once inside the cell, the mRNA can attach itself to the HIV within infected cells, making it much easier to locate the often hard-to-find virus. HIV mutates quickly, and the resulting large number ...

Responding to a request for comment on the ending of funding for projects on mRNA HIV vaccines, HHS Press Secretary Emily Hilliard gave a similar statement, repeating that the technology is ...